Innovational combination of hetero-bifunctional N-PEG quinoline scaffolds derivatives with improved anticancer activity against breast and colon cancer cell lines and P-glycoprotein, cytochrome p450 enzyme activity prediction
作者:Mahesh GAIDHANE、Ajay GHATOLE、Kushal LANJEWAR、Kishor HATZADE
DOI:10.3906/kim-2006-13
日期:——
Polyethylene glycol (PEG) is a polymer that is widely used as a carrier for drug delivery systems (DDS). A library of N-PEGylated quinoline derivatives of PEG molecular weight 200 was prepared rapidly after the activation of PEGs using maleic anhydride. Quinoline with a polymer backbone is essential as new material. PEG is a water-soluble nonionic polymer approved by food and drug organizations for medicine applications. Because of its nontoxic grapheme, it is widely utilized in numerous biochemical, cosmetic, pharmaceutical, and industrialized applications. The modern SwissADME is a web tool that stretches free admittance to a pool of hasty, yet solid, clarifying models for physicochemical properties, pharmacokinetics, and therapeutic science. The present facile synthetic strategy can be a practical approach for incorporating polymeric carriers conjugated with drug moieties, either in the backbone of the polymer or as a terminal and pendant group on the polymer chains.
聚乙烯醇(PEG)是一种广泛用于药物输送系统(DDS)的聚合物。在对聚乙烯醇进行马来酸酐活化后,快速制备了PEG分子量为200的N-PEG化喹啉衍生物。具有聚合物主链的喹啉作为新材料至关重要。PEG是一种水溶性非离子聚合物,已获得食品和药品组织的批准用于医学应用。由于其无毒特性,它被广泛用于许多生化、化妆品、药品和工业应用中。现代SwissADME是一个网络工具,为物理化学性质、药物动力学和治疗科学提供了一系列快速且可靠的解释模型。当前的简便合成策略可以作为将带药物基团的聚合物载体结合的实用方法,无论是结合在聚合物的主链上,还是作为聚合物链上的末端和侧基。